Back to results
US 2013/0158238 A1Published application
Compositions and Methods for the Therapy and Diagnosis of Influenza
AssigneeTheraclone Sciences, Inc.
InventorsAndres G. Grandea, III, Gordon King, Thomas C. Cox, Ole Olsen, Jennifer Mitcham, Matthew Moyle, Phil Hammond
Life of this patent
Estimating the term…
Abstract
The present invention provides novel human anti-influenza antibodies and related compositions and methods. These antibodies are used in the diagnosis and treatment of influenza infection.
Claims1
An isolated fully human monoclonal anti-matrix 2 ectodomain (M2e) antibody comprising:
- a) a heavy chain sequence comprising the amino acid sequence of SEQ ID NO:
- 44 and a light chain sequence comprising amino acid sequence SEQ ID NO:
- 46;
- b) a heavy chain sequence comprising the amino acid sequence of SEQ ID NO:
- 319 and a light chain sequence comprising amino acid sequence SEQ ID NO:
- 46;
- c) a heavy chain sequence comprising the amino acid sequence of SEQ ID NO:
- 321 and a light chain sequence comprising amino acid sequence SEQ ID NO:
- 46;
- d) a heavy chain sequence comprising the amino acid sequence of SEQ ID NO:
- 50 and a light chain sequence comprising amino acid sequence SEQ ID NO:
- 52;
- e) a heavy chain sequence comprising the amino acid sequence of SEQ ID NO:
- 323 and a light chain sequence comprising amino acid sequence SEQ ID NO:
- 52;
- or
- f) a heavy chain sequence comprising the amino acid sequence of SEQ ID NO:
- 325 and a light chain sequence comprising amino acid sequence SEQ ID NO:
- 52.
16 more elements
Dependencies are inferred from the claim text.